Brief: Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity
15/04/2025 14:35
April 15 (Reuters) - Vivani Medical Inc VANI.O: VIVANI MEDICAL AND OKAVA EXPAND COLLABORATION TO DEVELOP OKV-119 FOR DOGS, TARGETING METABOLIC HEALTH AND LONGEVITY VIVANI MEDICAL INC - FINANCIAL TERMS OF EXPANDED AGREEMENT NOT DISCLOSED Source text: ID:nGNX9rPJ5X Further company coverage: VANI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivani Medical
See all newsVivani Medical Q2 net loss narrows as expenses fall
Vivani Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Vivani Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia